Cargando…
Interleukin-9 in Immunopathology of Trypanosoma cruzi Experimental Infection
Chagas’ disease is a parasitosis caused by Trypanosoma cruzi, which affects approximately 8 million people worldwide. The balance between pro- and anti-inflammatory cytokines produced during immunological responses contributes to disease prognosis and progression. Parasite tissue persistence can ind...
Autores principales: | Silva, Nadjania Saraiva de Lira, Orikaza, Cristina Mary, de Santana, Fabiana Rodrigues, dos Santos, Luana Aguiar, Salu, Bruno Ramos, Oliva, Maria Luiza Vilela, Sinigaglia, Rita de Cássia, Mortara, Renato Arruda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554238/ https://www.ncbi.nlm.nih.gov/pubmed/34722343 http://dx.doi.org/10.3389/fcimb.2021.756521 |
Ejemplares similares
-
Modulation of STAT-1, STAT-3, and STAT-6 activities in THP-1 derived macrophages infected with two Trypanosoma cruzi strains
por: Oliveira, Melissa Martins, et al.
Publicado: (2022) -
Trypanosoma cruzi: single cell live imaging inside infected tissues
por: Ferreira, Bianca Lima, et al.
Publicado: (2016) -
BALB/c and C57BL/6 Mice Cytokine Responses to Trypanosoma cruzi Infection Are Independent of Parasite Strain Infectivity
por: Ferreira, Bianca L., et al.
Publicado: (2018) -
Immunopathological Aspects of Experimental Trypanosoma cruzi Reinfections
por: Reis Machado, Juliana, et al.
Publicado: (2014) -
Ablation of the P21 Gene of Trypanosoma cruzi Provides Evidence of P21 as a Mediator in the Control of Epimastigote and Intracellular Amastigote Replication
por: Teixeira, Thaise Lara, et al.
Publicado: (2022)